Viewing Study NCT00017992

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 3:14 PM
Ignite Modification Date: 2026-02-02 @ 5:11 PM
Study NCT ID: NCT00017992
Status: UNKNOWN
Last Update Posted: 2005-06-24
First Post: 2001-06-23
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Emtricitabine Given Once A Day With Other Anti-HIV Drugs in Children With HIV
Sponsor: Triangle Pharmaceuticals
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None HIV Infections View
Keywords:

Keywords

Keyword Brief Keyword Text View
None HIV-1 View
None Drug Administration Schedule View
None Stavudine View
None HIV Protease Inhibitors View
None Ritonavir View
None Reverse Transcriptase Inhibitors View
None Anti-HIV Agents View
None Pharmacokinetics View
None ABT 378 View
None emtricitabine View